PROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-710-21
Published July 30, 2025 · Recall initiated: April 21, 2025
Summary
FDA records drug Class II recall D-0538-2025, published July 30, 2025 and initiated April 21, 2025. Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office; Status: Ongoing; Reported quantity: 6 Pre-filled syringes; Lot: Lot: 1180924, Expiration date: 6/30/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations; potential temperature excursions due to transit delays
What to do
Voluntary: Firm initiated · Letter
Get an email if PROLIA has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PROLIA
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Distributor
- Within the U.S - OH, VA, FL.
- Lot
- Lot: 1180924, Expiration date: 6/30/2027.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAclomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boulevard, Suite 500,July 30, 2025
- FDAEVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by:July 30, 2025
- FDATropicamide-Proparacaine-Phenylephrine-Ketorolac, Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5mL, 2x5MLJuly 30, 2025
- FDABENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.July 30, 2025
- FDAEpinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Imprimis NJOF, 1705July 30, 2025
- FDAProlia (denosumab) Injection, 60 mg/mL, 1 x 60 mg Single Use Prefilled Syringe per carton, Rx only,November 13, 2013
Questions about this recall
Was PROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-710-21 recalled?
Yes. FDA published recall D-0538-2025 on July 30, 2025. Reported hazard: CGMP Deviations; potential temperature excursions due to transit delays
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PROLIA.